Stock LJPC LA JOLLA PHARMACEUTICAL COMPANY
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News La Jolla Pharmaceutical Company

Equities

LJPC

US5034596040

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Termination of a Material Definitive Agreement - Form 8-K
PU
LA JOLLA PHARMACEUTICAL CO : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
La Jolla Pharmaceutical Announces Management Changes
CI
La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index
CI
La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from S&P TMI Index
CI
Innoviva, Inc. completed the acquisition of La Jolla Pharmaceutical Company for approximately $210 million.
CI
LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Tranche Update on La Jolla Pharmaceutical Company's Equity Buyback Plan announced on November 17, 2021.
CI
La Jolla Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC
BU
Twitter, Las Vegas Sands fall; Mullen, La Jolla rise
AQ
Sector Update: Health Care Stocks Edging Lower at Close
MT
Top Midday Gainers
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LJPC Stock
  4. News La Jolla Pharmaceutical Company